Earnings Report: Here’s what to expect from ANCHIANO THERAP/S (NASDAQ:ANCN)

Earnings results for ANCHIANO THERAP/S (NASDAQ:ANCN)

Estimate Momentum measures change in analyst sentiment over time and may be an indicator of future price movements. The Change in Consensus chart shows the current, 1 week ago, and 1 month ago consensus earnings per share (EPS*) forecasts. For the fiscal quarter endingJun 2020 , the consensus EPS* forecast has remained the same over the past week at -0.55 and remained the same over the past month at -0.55. none raised and none lowered their forecast. For the fiscal year ending Dec 2020 , the consensus EPS* forecast has remained the same over the past week at -2.25 and remained the same over the past month at -2.25 . none raised and none lowered their forecast.

Analyst Opinion on ANCHIANO THERAP/S (NASDAQ:ANCN)

3 Wall Street analysts have issued ratings and price targets for ANCHIANO THERAP/S in the last 12 months. Their average twelve-month price target is $16.00, suggesting that the stock has a possible upside of 1,279.31%. The high price target for ANCN is $16.00 and the low price target for ANCN is $16.00. There are currently 3 hold ratings for the stock, resulting in a consensus rating of “Hold.”

ANCHIANO THERAP/S has received a consensus rating of Hold. The company’s average rating score is 2.00, and is based on no buy ratings, 3 hold ratings, and no sell ratings. According to analysts’ consensus price target of $16.00, ANCHIANO THERAP/S has a potential upside of 1,279.3% from its current price of $1.16. ANCHIANO THERAP/S has received no research coverage in the past 90 days.

Dividend Strength: ANCHIANO THERAP/S (NASDAQ:ANCN)

ANCHIANO THERAP/S does not currently pay a dividend. ANCHIANO THERAP/S does not have a long track record of dividend growth.

Insiders buying/selling: ANCHIANO THERAP/S (NASDAQ:ANCN)

In the past three months, ANCHIANO THERAP/S insiders have not sold or bought any company stock. Only 6.88% of the stock of ANCHIANO THERAP/S is held by insiders. Only 7.49% of the stock of ANCHIANO THERAP/S is held by institutions.

Earnings and Valuation of ANCHIANO THERAP/S (NASDAQ:ANCN

Earnings for ANCHIANO THERAP/S are expected to decrease in the coming year, from ($2.25) to ($3.00) per share. The P/E ratio of ANCHIANO THERAP/S is -0.74, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. The P/E ratio of ANCHIANO THERAP/S is -0.74, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. ANCHIANO THERAP/S has a P/B Ratio of 0.58. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

More latest stories: here